CANCER 2026 Bratati Karmakar
Garvan, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
A phase I/II study to assess the toxicity and preliminary efficacy of SUBA-itraconazole and dual checkpoint inhibitor cadonilimab as maintenance therapy in advanced pancreatic ductal adenocarcinoma (#171)
5:40 PM
Bratati Karmakar
Welcome Reception & Poster Session 1